课题基金 / 基金详情

Improving outcomes for women diagnosed with mucinous ovarian cancer

Improving outcomes for women diagnosed with mucinous ovarian cancer
改善诊断患有粘液性卵巢癌的女性的预后
批准号:
nhmrc : 1045783
负责人:
A/Pr Clare Scott
金额:
$39.89万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2013
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2013-01-01 至 2016-12-31

项目摘要

项目成果

A/Pr Clare Scott的其他基金

相似基金

相关文献

中文摘要
翻译
黏液性卵巢癌(MOC)不同于其他卵巢癌,但很少有研究描述这种亚型特有的遗传变化。它经常与其他器官的转移相混淆,并且对标准卵巢癌治疗反应不佳。如果MOC与来自其他器官的黏液性肿瘤比其他卵巢癌更相似,则可能更好地使用化疗药物治疗其他黏液性肿瘤。
英文摘要
Mucinous ovarian cancer (MOC) is different from other ovarian cancers but few studies have characterized the genetic changes specific to this subtype. It is often confused with metastases from other organs and does not respond well to standard ovarian cancer therapies. If MOC is more similar to mucinous cancers from other organs than other ovarian cancers, it may be better treated with chemotherapeutics that show success with other mucinous tumours.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exploring the DNA repair capacity of oocytes
  • 批准号:
    nhmrc : 1100219
  • 项目类别:
    Project Grants
  • 资助金额:
    $51.1万
  • 财政年份:
    2016
  • 负责人:
    A/Pr Clare Scott
  • 依托单位:
Engineering MYCN models of high-grade serous ovarian cancer (HGSC)
Molecular subtype specific therapy in high grade serous ovarian cancer
  • 批准号:
    nhmrc : 1081178
  • 项目类别:
    Project Grants
  • 资助金额:
    $55.49万
  • 财政年份:
    2015
  • 负责人:
    A/Pr Clare Scott
  • 依托单位:
Tailoring targeted therapy to DNA repair-defective High-Grade Serous Ovarian Cancer
海外基金